Alzheimer's Research & Therapy

Visit Our SFN 2019 Page

Visit our page dedicated to SFN 2019. Find our top article collections, featured journals and latest blog posts.

Find out more

Call for Papers - Open Collections

10 Years of Alzheimer's Research & Therapy

Thematic Series

Microbiota-gut-brain jigsaw

The microbiota-gut-brain axis

Cross-journal collection

Thematic Series - Subject Cognitive Decline

Neuron

Target populations for early diagnosis, disease course prediction and interventions in Alzheimer’s disease are a major focus of current research. Subjective cognitive decline (SCD) has emerged as a pre-mild cognitive impairment (pre-MCI) at risk condition of dementia and cognitive decline.

Read our new thematic series, guest edited by José Luis Molinuevo, Frank Jessen & Wiesje Van der Flier

Content type: Research
| 10 October 2019

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Authors: Inger van Steenoven, Wiesje M. van der Flier, Philip Scheltens, Charlotte E. Teunissen and Afina W. Lemstra
Content type: Research
| 14 September 2019

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

Authors: Simon Sjödin, Gunnar Brinkmalm, Annika Öhrfelt, Lucilla Parnetti, Silvia Paciotti, Oskar Hansson, John Hardy, Kaj Blennow, Henrik Zetterberg and Ann Brinkmalm
Content type: Research
| 14 September 2019

CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology

Authors: J. S. Miners, P. G. Kehoe, S. Love, H. Zetterberg and K. Blennow
Content type: Research
| 12 September 2019

Sleep experiences during different lifetime periods and in vivo Alzheimer pathologies

Authors: Young Min Choe, Min Soo Byun, Dahyun Yi, Jun Ho Lee, So Yeon Jeon, Bo Kyung Sohn, Yu Kyeong Kim, Seong A Shin, Chul-Ho Sohn, Yu Jin Lee and Dong Young Lee
Content type: Research
| 12 September 2019

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

Authors: Arno de Wilde, Juhan Reimand, Charlotte E. Teunissen, Marissa Zwan, Albert D. Windhorst, Ronald Boellaard, Wiesje M. van der Flier, Philip Scheltens, Bart N. M. van Berckel, Femke Bouwman and Rik Ossenkoppele

Most recent articles RSS

View all articles

Content type: Research
| 15 March 2011

Stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic mice

Authors: Bin Li, Maria E Gonzalez-Toledo, Chun-Shu Piao, Allen Gu, Roger E Kelley and Li-Ru Zhao
Content type: Review
| 24 December 2014

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease

Authors: Robert Vassar
Content type: Research
| 3 July 2014

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Authors: Jeffrey L Cummings, Travis Morstorf and Kate Zhong
Content type: Review
| 11 June 2014

Cerebral microbleeds: overview and implications in cognitive impairment

Authors: Sergi Martinez-Ramirez, Steven M Greenberg and Anand Viswanathan
Content type: Research
| 1 August 2014

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Authors: Eva Kontsekova, Norbert Zilka, Branislav Kovacech, Petr Novak and Michal Novak

Most accessed articles RSS

View all articles

Aims and scope

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.

Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.

Resilience in Dementia Series

Wikimedia Commons

Brain resilience is the process of adapting well in the face of significant sources of stress, such as Alzheimer’s disease pathology, other neurodegenerative conditions or biological aging. This thematic series provides a comprehensive overview of what factors contribute to brain resilience and how this affects brain health and cognitive function.

Read the articles

Guest Editor: Rik Ossenkoppele

Do you have an idea for a thematic series? Let us know!

Latest Tweets

Alzheimer's blogs from BMC

World Alzheimer’s Month: Let’s talk about dementia to end the stigma

20 September 2019
Spotlight on Alzheimer’s Research: Brain Awareness Week 2019

27 February 2019
Exergaming to improve complex motor-cognitive performances in patients suffering from dementia

07 February 2019

Alzheimer's Research & Therapy

Visit Our SFN 2019 Page

Call for Papers - Open Collections

Thematic Series - Subject Cognitive Decline

Articles

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology

Sleep experiences during different lifetime periods and in vivo Alzheimer pathologies

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

Stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic mice

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Cerebral microbleeds: overview and implications in cognitive impairment

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Aims and scope

Resilience in Dementia Series

Do you have an idea for a thematic series? Let us know!

Latest Tweets

Alzheimer's blogs from BMC

World Alzheimer’s Month: Let’s talk about dementia to end the stigma

Spotlight on Alzheimer’s Research: Brain Awareness Week 2019

Exergaming to improve complex motor-cognitive performances in patients suffering from dementia

Affiliated with

Annual Journal Metrics

Alzheimer's Research & Therapy

Contact us